Newsletter insight

VaxThera Expands Vaccine Manufacturing Cooperation

Perspectives from the HPC business newsletter.

← All business news VaxThera Expands Vaccine Manufacturing Cooperation
A report published on 2 November said South Korea’s GC Biopharma signed a 59.2 billion won agreement with Colombia’s VaxThera for influenza-vaccine materials and production expertise.
A report published on 2 November said South Korea’s GC Biopharma signed a 59.2 billion won agreement with Colombia’s VaxThera for influenza-vaccine materials and production expertise. The cooperation creates potential demand for manufacturing support, packaging, distribution and healthcare supply-chain services. HPC can help identify qualified suppliers and partners.
Valid number

Read our Privacy Policy to understand how Colombia Business Wave handles your enquiry and contact details.

Solve the addition to enable the send button.

Let’s start a conversation

Let’s find the right next step for you.

Share your questions and goals. Our team will help you explore the support and opportunities available.

Contact our team